The term uraemic cardiomyopathy refers to the cardiac abnormalities that are seen in
patients with chronic kidney disease (CKD). Historically, this term was used to describe a …

Insulin resistance (IR) is an early metabolic alteration in chronic kidney disease (CKD)
patients, being apparent when the glomerular filtration rate is still within the normal range …

The management of hyperglycemia in patients with kidney failure is complex, and the goals
and methods regarding glycemic control in chronic kidney disease (CKD) are not clearly …

Background and aims Routine, periodic fasting is associated with a lower prevalence of
coronary artery disease (CAD). Animal studies show that fasting may increase longevity and …

Many disease processes activate a cellular stress response that initiates a cascade of
inflammation and damage. However, this process also triggers a tissue protection and repair …

Recent studies have shown that erythropoietin (EPO) is an effective neuroprotective and
neurotrophic agent for neurological disorders, such as traumatic brain injury and Alzheimer's …

End-stage renal disease (ESRD) is a common but profound clinical condition, and it is
associated with extremely increased morbidity and mortality. ESRD can represent four major …

Erythropoietin (EPO) has multiple biological functions, including the modulation of glucose
metabolism. However, the mechanisms underlying the action of EPO are still obscure. This …

Erythropoietin (EPO) contributes to insulin resistance in fat and muscle. In the present study,
the role and mechanism of EPO in hepatic insulin resistance were investigated in HepG2 …

Contributing factors to the abnormalities in glucose homeostasis in people with kidney
impairment are shown in Fig. 1. Multifactorial alterations in glucose homeostasis occur when …